Los puntos clave no están disponibles para este artículo en este momento.
The findings provide grounds for optimism that patients with advanced cancer may benefit from taking part in symptom control trials, supporting the paradigm that participation in symptom control research should be encouraged in this population.
Middlemiss et al. (Fri,) studied this question.